Keywords: galapagos, biofocus, unit, three-year, deal, roche, belgian
Galapagos' BioFocus unit in three-year deal with Roche
Article | 03 April 2006
Belgian genomics-based drug discovery firm Galapagos says that its service division, BioFocus, has entered into a three-year collaboration with Swiss ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
